Over the next 5–10 years, work will focus on the complex balance of standardization of care for children with rheumatic disease and individualization of therapeutic interventions. International ...

Please provide your email address to receive an email when new articles are posted on . There is significant variation in the patterns of methotrexate use prior to initiating etanercept in patients ...

Oct. 28 -- MONDAY, Oct. 27 (HealthDay News) -- The drugs etanercept and methotrexate are safe and effective for long-term, continuous treatment of juvenile rheumatoid arthritis, new research finds. In ...

Elevated levels of the inflammatory biomarkers myeloid related protein 8/14 predict an increased risk of relapse following withdrawal of methotrexate therapy in children with juvenile idiopathic ...

Compared with sulfasalazine monotherapy or methotrexate with initial prednisone bridging, etanercept and methotrexate combination therapy was associated with more clinical improvement in patients with ...

(HealthDay News) – Oral and injected methotrexate are equally effective for treating children with juvenile idiopathic arthritis, according to a study published online May 30 in Arthritis Care & ...

For patients with juvenile idiopathic arthritis in remission, withdrawal of treatment with the drug methotrexate over 12 months vs. 6 months did not reduce the rate of relapse, according to a new ...

Kaitlin Preble's daughter has battled juvenile idiopathic arthritis since age 3. For the past decade, Kaitlin Preble of Tucson, Arizona, said she has gone to her local pharmacy each month to pick up ...

ML Becker's work was supported by the Katharine B Richardson Grant, the Children's Mercy Young Investigator Award, the Paul Henson Immunology Research Award, the Kansas City Area Life Sciences Award, ...